Brevan Howard Capital Management’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,899
Closed -$46.4K 1043
2024
Q1
$46.4K Buy
+3,899
New +$46.4K ﹤0.01% 893